| Kurt D Michelkamp, RN | |
|
7948 County Road A, Almond, WI 54909-9556 | |
| (715) 366-8277 | |
| Not Available |
| Full Name | Kurt D Michelkamp |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | 7948 County Road A, Almond, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295063485 | NPI | - | NPPES |
| 146810-030 | Other | WI | RN LICENSE |
| 35033900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 146810-030 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kurt D Michelkamp, RN 3727 North Point Dr, Stevens Point, WI 54481-1233 Ph: (715) 341-6970 | Kurt D Michelkamp, RN 7948 County Road A, Almond, WI 54909-9556 Ph: (715) 366-8277 |
News Archive
Walgreens (NYSE:WAG) today launched a broad initiative for 90-day prescriptions that promotes delivery of maintenance and chronic care medication through its national network of more than 7,000 community pharmacies and employer worksite centers.
Nucleoside analogs such as cytarabine and gemcitabine are powerful anticancer agents, but a simple chemical modification that causes them to assemble into stable nanoparticles could make them even more valuable in the treatment of a wide variety of cancers.
Despite the fact that colon cancer screening saves lives, the majority of U.S. adults age 50 and over who are eligible for such screening fail to take advantage of it. Consider the numbers: In 2000, only 16.3 million of 80 million eligible adults received colon cancer screening such as the fecal occult blood test, sigmoidoscopy or colonoscopy.
Researchers have uncovered a potential biological factor that may contribute to disparities in prostate cancer incidence and mortality between African-American and non-Hispanic white men in the United States, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded more than $1.4 million from the National Cancer Institute of the National Institutes of Health to create a potential new drug to attack the malignant cells that cause chronic lymphocytic leukemia (CLL), which is the most common leukemia in the Western world.
› Verified 5 days ago
Michael R Rajkowski, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7948 County Road A, Almond, WI 54909 Phone: 715-366-8277 | |
Ruby P Rajkowski, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7948 County Road A, Almond, WI 54909 Phone: 715-366-8277 Fax: 715-366-8278 |